Henry J. Fuchs - 15 Mar 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: President, Worldwide R&D
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 15 Mar 2022
Net transactions value: -$1,129,492
Form type: 4
Filing time: 17 Mar 2022, 21:47:02 UTC
Previous filing: 10 Mar 2022
Next filing: 10 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+38,790	+33%	$0.000000	158,113	15 Mar 2022	Direct	F1
transaction	BMRN	Common Stock	Tax liability	$947,145	-12,101	-7.7%	$78.27	146,012	15 Mar 2022	Direct
transaction	BMRN	Common Stock	Tax liability	$182,346	-2,259	-1.5%	$80.72	143,753	16 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Award	$0	+35,830		$0.000000	35,830	15 Mar 2022	Common Stock	35,830	$78.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on March 15, 2022. Price not applicable.
F2	Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.